Remarkable activity of novel agents bortezomib and thalidomi…
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Article, Chapter
Full text availability for this item
Journal:
BloodOpens in new Window
Collection:
Elsevier ScienceDirect Journals
Coverage:
- 1946-01-01~present
Journal:
BloodOpens in new Window
Collection:
American Society of Hematology
Coverage:
- 1946~12 months ago